Kyowa: Improving Lives with Health Science
KYOWA HAKKO USA, INC. is the North American sales office for KYOWA HAKKO BIO CO., LTD., and distributor for Kyowa Pharma Chemical Co. As an international health ingredients manufacturer and a world leader in the development, manufacturing and marketing of nutraceuticals, pharmaceuticals and food products, Kyowa is a pioneer in the development and application of fermentation technology and maintains an ongoing commitment to research, developing innovative new products and quality management.
Kyowa is the maker of branded ingredients including Setria® Glutathione, IMMUSE™ Lactococcus lactis strain Plasma, Cognizin® Citicoline, Pantesin® Pantethine, VELOX® Patented Performance Blend, and EYEMUSE™ Lacticaseibacillus paracasei KW3110.
Branded Ingredients for Targeted Health Benefits
Kyowa Hakko Bio Celebrates Grand Opening of Expanded Cognizin® Citicoline Manufacturing Facility in Hofu, Japan
Kyowa Hakko Bio Co., Ltd. (Kyowa Hakko Bio) & Kyowa Hakko USA, Inc (Kyowa), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), is thrilled to announce the celebration of the grand opening of its expanded citicoline manufacturing facilities at the Kyowa Hakko Bio Yamaguchi Production Center, situated in Hofu City, Yamaguchi Prefecture, Japan.
RYSE Supplements, in collaboration with Kyowa Hakko, has announced the launch of 16 newly reformulated SKUs featuring the premium ingredient Cognizin® Citicoline.